特發性肺纖維化中呼吸道病毒的研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

QI Huaiqing ,  GUO Jun

清華大學臨床醫學院清華大學附屬北京清華長庚醫院呼吸與危重癥醫學科（北京 102218）;

Corresponding?author：

GUO Jun, Email: 1617721000@qq.com

Keywords：

DOI：

10.7507/1671-6205.202311016

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： QI Huaiqing, GUO Jun. 特發性肺纖維化中呼吸道病毒的研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2024, 23(10): 752-755. doi: 10.7507/1671-6205.202311016 Copy

1.	Maher TM, Bendstrup E, Dron L, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res, 2021, 22(1): 197.
2.	Ye Z, Hu Y. TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med, 2021, 48(1): 132.
3.	Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2022, 205(9): e18-e47.
4.	Mei Q, Liu Z, Zuo H, et al. Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. Front Pharmacol, 2022, 12: 797292.
5.	歐陽小荔, 彭紅. 特發性肺纖維化預后的影響因素. 中國呼吸與危重監護雜志, 2021, 20(11): 824-830.
6.	Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med, 2011, 208(7): 1339-1350.
7.	Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2018, 198(5): e44-e68.
8.	Raghu G, Collard HR, Egan JJ, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
9.	Collard HR, Ryerson CJ, Corte TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med, 2016, 194(3): 265-275.
10.	Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J, 2006, 27(1): 143-150.
11.	Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax, 1996, 51(3): 315-317.
12.	Ueda T, Ohta K, Suzuki N, et al. Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus. Am Rev Respir Dis, 1992, 146(1): 266-268.
13.	Irving WL, Day S, Johnston ID. Idiopathic Pulmonary Fibrosis and Hepatitis C Virus Infection. Am Rev Respi Dis, 1993, 148(6pt1): 1683-1684.
14.	Kuwano K, Nomoto Y, Kunitake R, et al. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J, 1997, 10(7): 1445-1449.
15.	Egan J, Woodcock A, Stewart J. Viruses and idiopathic pulmonary fibrosis. Eur Respir J, 1997, 10(7): 1433-1437.
16.	Drake TM, Docherty AB, Harrison EM, et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am J Respir Crit Care Med, 2020, 202(12): 1656-1665.
17.	Goto Y, Sakamoto K, Fukihara J, et al. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review. Front Med (Lausanne), 2022, 9: 815924.
18.	Yagi K, Huffnagle GB, Lukacs NW, et al. The Lung Microbiome during Health and Disease. Int J Mol Sci, 2021, 22(19): 10872.
19.	Dickson RP, Erb-Downward JR, Martinez FJ, et al. The Microbiome and the Respiratory Tract. Annu Rev Physiol, 2016, 78(1): 481-504.
20.	Hilty M, Burke C, Pedro H, et al. Disordered Microbial Communities in Asthmatic Airways. PLoS One, 2010, 5(1): e8578.
21.	Tipton L, Ghedin E, Morris A. The lung mycobiome in the next-generation sequencing era. Virulence, 2017, 8(3): 334-341.
22.	Young JC, Chehoud C, Bittinger K, et al. Viral Metagenomics Reveal Blooms of Anelloviruses in the Respiratory Tract of Lung Transplant Recipients. Am J Transplant, 2015, 15(1): 200-209.
23.	Wylie K M. The Virome of the Human Respiratory Tract. Clinics in Chest Medicine, 2017, 38(1): 11-19.
24.	Tamayo-Trujillo R, Guevara-Ramírez P, Cadena-Ullauri S, et al. Human virome: Implications in cancer. Heliyon, 2023, 9(3): e14086.
25.	Cao Z, Sugimura N, Burgermeister E, et al. The gut virome: A new microbiome component in health and disease. EBioMedicine, 2022, 81: 104113.
26.	Tang YW, Johnson J E, Browning P J, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol, 2003, 41(6): 2633-2640.
27.	Egan JJ, Adamali HI, Lok SS, et al. Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study. Pulm Med, 2011, 2011: 1-5.
28.	Moore BB, Moore TA. Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation. Ann Am Thora Soc, 2015, 12(Suppl 2): S186-S192.
29.	Hewitt RJ, Molyneaux PL. The respiratory microbiome in idiopathic pulmonary fibrosis. Ann Transl Med, 2017, 5(12): 250-250.
30.	Tong X, Su F, Xu X, et al. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients. Front Cell Infect Microbiol, 2019, 9: 149.
31.	Li Y, Gao J, Wang G, et al. Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-β1. Mol Med Rep, 2016, 14(2): 1297-1301.
32.	Stewart JP, Egan JJ, Ross AJ, et al. The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 1999, 159(4 Pt 1): 1336–1341.
33.	Manika K, Alexiou-Daniel S, Papakosta D, et al. Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, 2007, 24(2): 134-140.
34.	Wootton SC, Kim DS, Kondoh Y, et al. Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 2011, 183(12): 1698-1702.
35.	Ushiki A, Yamazaki Y, Hama M, et al. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Respir Investig, 2014, 52(1): 65-70.
36.	Santos GC, Parra ER, Stegun FW, et al. Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. Braz J Med Biol Res, 2013, 46(11): 985-992.
37.	Weng D, Chen XQ, Qiu H, et al. The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Mediators Inflamm, 2019, 2019: 5160694.
38.	Calabrese F, Kipar A, Lunardi F, et al. Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis. PLoS One, 2013, 8(2): e55715.

1. Maher TM, Bendstrup E, Dron L, et al. Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res, 2021, 22(1): 197.
2. Ye Z, Hu Y. TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review). Int J Mol Med, 2021, 48(1): 132.
3. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2022, 205(9): e18-e47.
4. Mei Q, Liu Z, Zuo H, et al. Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis. Front Pharmacol, 2022, 12: 797292.
5. 歐陽小荔, 彭紅. 特發性肺纖維化預后的影響因素. 中國呼吸與危重監護雜志, 2021, 20(11): 824-830.
6. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med, 2011, 208(7): 1339-1350.
7. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med, 2018, 198(5): e44-e68.
8. Raghu G, Collard HR, Egan JJ, et al. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
9. Collard HR, Ryerson CJ, Corte TJ, et al. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med, 2016, 194(3): 265-275.
10. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J, 2006, 27(1): 143-150.
11. Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax, 1996, 51(3): 315-317.
12. Ueda T, Ohta K, Suzuki N, et al. Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus. Am Rev Respir Dis, 1992, 146(1): 266-268.
13. Irving WL, Day S, Johnston ID. Idiopathic Pulmonary Fibrosis and Hepatitis C Virus Infection. Am Rev Respi Dis, 1993, 148(6pt1): 1683-1684.
14. Kuwano K, Nomoto Y, Kunitake R, et al. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J, 1997, 10(7): 1445-1449.
15. Egan J, Woodcock A, Stewart J. Viruses and idiopathic pulmonary fibrosis. Eur Respir J, 1997, 10(7): 1433-1437.
16. Drake TM, Docherty AB, Harrison EM, et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. Am J Respir Crit Care Med, 2020, 202(12): 1656-1665.
17. Goto Y, Sakamoto K, Fukihara J, et al. COVID-19-Triggered Acute Exacerbation of IPF, an Underdiagnosed Clinical Entity With Two-Peaked Respiratory Failure: A Case Report and Literature Review. Front Med (Lausanne), 2022, 9: 815924.
18. Yagi K, Huffnagle GB, Lukacs NW, et al. The Lung Microbiome during Health and Disease. Int J Mol Sci, 2021, 22(19): 10872.
19. Dickson RP, Erb-Downward JR, Martinez FJ, et al. The Microbiome and the Respiratory Tract. Annu Rev Physiol, 2016, 78(1): 481-504.
20. Hilty M, Burke C, Pedro H, et al. Disordered Microbial Communities in Asthmatic Airways. PLoS One, 2010, 5(1): e8578.
21. Tipton L, Ghedin E, Morris A. The lung mycobiome in the next-generation sequencing era. Virulence, 2017, 8(3): 334-341.
22. Young JC, Chehoud C, Bittinger K, et al. Viral Metagenomics Reveal Blooms of Anelloviruses in the Respiratory Tract of Lung Transplant Recipients. Am J Transplant, 2015, 15(1): 200-209.
23. Wylie K M. The Virome of the Human Respiratory Tract. Clinics in Chest Medicine, 2017, 38(1): 11-19.
24. Tamayo-Trujillo R, Guevara-Ramírez P, Cadena-Ullauri S, et al. Human virome: Implications in cancer. Heliyon, 2023, 9(3): e14086.
25. Cao Z, Sugimura N, Burgermeister E, et al. The gut virome: A new microbiome component in health and disease. EBioMedicine, 2022, 81: 104113.
26. Tang YW, Johnson J E, Browning P J, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol, 2003, 41(6): 2633-2640.
27. Egan JJ, Adamali HI, Lok SS, et al. Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study. Pulm Med, 2011, 2011: 1-5.
28. Moore BB, Moore TA. Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation. Ann Am Thora Soc, 2015, 12(Suppl 2): S186-S192.
29. Hewitt RJ, Molyneaux PL. The respiratory microbiome in idiopathic pulmonary fibrosis. Ann Transl Med, 2017, 5(12): 250-250.
30. Tong X, Su F, Xu X, et al. Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients. Front Cell Infect Microbiol, 2019, 9: 149.
31. Li Y, Gao J, Wang G, et al. Latent cytomegalovirus infection exacerbates experimental pulmonary fibrosis by activating TGF-β1. Mol Med Rep, 2016, 14(2): 1297-1301.
32. Stewart JP, Egan JJ, Ross AJ, et al. The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 1999, 159(4 Pt 1): 1336–1341.
33. Manika K, Alexiou-Daniel S, Papakosta D, et al. Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, 2007, 24(2): 134-140.
34. Wootton SC, Kim DS, Kondoh Y, et al. Viral Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med, 2011, 183(12): 1698-1702.
35. Ushiki A, Yamazaki Y, Hama M, et al. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Respir Investig, 2014, 52(1): 65-70.
36. Santos GC, Parra ER, Stegun FW, et al. Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation. Braz J Med Biol Res, 2013, 46(11): 985-992.
37. Weng D, Chen XQ, Qiu H, et al. The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Mediators Inflamm, 2019, 2019: 5160694.
38. Calabrese F, Kipar A, Lunardi F, et al. Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis. PLoS One, 2013, 8(2): e55715.

Previous Article
經鼻高流量氧療在急性呼吸窘迫綜合征中的應用
Next Article
鐵穩態及鐵死亡與慢性阻塞性肺疾病相關性研究進展

Chinese Journal of Respiratory and Critical Care Medicine

特發性肺纖維化中呼吸道病毒的研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content